2017 | Transverse dental compensation in relation to sagittal and transverse skeletal discrepancies in skeletal Class III patients | AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS |
2015 | Transverse testis ectopia: diagnostic and management algorithm | INTERNATIONAL JOURNAL OF UROLOGY |
2012 | Transvesicoscopic ureteral reimplantation in children with bilateral vesicoureteral reflux: surgical technique and results | JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES |
2023 | Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer | JOURNAL OF CLINICAL ONCOLOGY |
2022 | Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Final overall survival (OS) results from a randomized, multicenter, open-label, phase 2 study (DESTINY-Gastric01) | JOURNAL OF CLINICAL ONCOLOGY |
2022 | Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
2020 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
| NEW ENGLAND JOURNAL OF MEDICINE |
2020 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
2022 | Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer | NEW ENGLAND JOURNAL OF MEDICINE |
2017 | Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study | LANCET ONCOLOGY |
2010 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. | LANCET |
2023 | Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer - Authors' reply | LANCET GASTROENTEROLOGY & HEPATOLOGY |
2023 | Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14) | LANCET GASTROENTEROLOGY & HEPATOLOGY |
2009 | Traumatic axillary ecchymoses in a golfer. | CLINICAL AND EXPERIMENTAL DERMATOLOGY |
2008 | Traumatic Experiences and Mental Health of North Korean Refugees in South Korea
| PSYCHIATRY INVESTIGATION |
2013 | Traumatic Incus Dislocation Into the External Auditory Canal | OTOLOGY & NEUROTOLOGY |
2009 | Traumatic neuroma of the right hepatic duct undertaken right hemihepatectomy | ANZ JOURNAL OF SURGERY |
2007 | Traumatic tricuspid regurgitation following cardiac massage
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2011 | Traumatic ventricular septal defect in a 4-year-old boy after blunt chest injury
| Korean Journal of Pediatrics |
1980 | Trazodone이 가토 혈중 주정농도에 미치는 영향에 관한 실험적 연구 | Thesis |